PWP
ABBV icon

Prasad Wealth Partners’s AbbVie ABBV Stock Holding History

Prasad Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$289K Buy
1,328
+12
+0.9% +$2.66K 0.08% 110
2025
Q4 		$301K Buy
+1,316
New +$300K 0.08% 107

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Prasad Wealth Partners's ABBV Position: Q1 2026 in Review

Prasad Wealth Partners increased its AbbVie (ABBV) stake by 0.91% in Q1 2026, buying an estimated $2.66K and bringing the position to 1,328 shares worth $289K. The position accounts for 0.08% of the portfolio, ranked #110.

Prasad Wealth Partners first reported a position in ABBV in Q4 2025 and has held it in 2 quarters since. The position peaked at $301K in Q4 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Prasad Wealth Partners held 1,328 shares of AbbVie worth $289K as of Q1 2026.
  • Prasad Wealth Partners bought 12 AbbVie shares in Q1 2026, an estimated $2.66K.
  • AbbVie made up 0.08% of Prasad Wealth Partners's portfolio in Q1 2026, its #110 holding.
  • Prasad Wealth Partners first reported a position in AbbVie in Q4 2025 and has held it in 2 quarters since.
  • Prasad Wealth Partners's AbbVie position peaked at $301K in Q4 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Prasad Wealth Partners's 13F filing for Q1 2026, filed 27 Apr 2026.